Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Frankfurt - Delayed Quote EUR

Amgen Inc. (AMG.F)

Compare

294.00

-4.20

(-1.41%)

At close: March 5 at 7:07:17 PM GMT+1

Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now

We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other undervalued stocks. How Will Tariffs Affect the Market? On March 5th, BBC reported that the US stock market had fallen after […]

Insider Monkey 4 hours ago

AMGN
Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out

Large-cap players including Gilead Sciences Amgen AbbVie Johnson & Johnson and Eli Lilly have seen inflows that nudged their share prices disproportionately higher. While Gilead, Amgen AbbVie and Johnson & Johnson have trailed the for the past three years, the analyst says there is room for upside in the near term and lifted the stocks’ price targets accordingly. Shares were up 0.2% to $115 on Wednesday, with the new price target suggesting a potential upside of just under 10%.

Barrons.com 4 hours ago

JNJ

ABBV

AMGN
Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025

Amgen (NasdaqGS:AMGN)'s recent affirmation of a $2.38 per share dividend for Q2 2025 could reflect investor confidence and perhaps aided in boosting its shares by 12% over the last quarter. The company's financial performance, highlighted by a revenue increase for 2024 despite a decrease in net income, indicates resilience. Concurrently, their product developments, such as the positive Phase III results for TEZSPIRE® and FDA approval for LUMAKRAS®, signal strong therapeutic advancements. The...

Simply Wall St. 8 hours ago

AMGN
With patent losses on the horizon, Amgen refocuses its business strategy

The company's vice president and general manager of U.S. business operations explains how Amgen is going to deliver on its “ambitious growth aspirations.”

Pharma Voice 17 hours ago

AMGN
AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the second quarter of 2025. The dividend will be paid on June 6, 2025, to all stockholders of record as of the close of business on May 16, 2025.

PR Newswire yesterday

AMGN
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks yesterday

AMGN
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 2 days ago

AMGN
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

The therapy is being developed jointly by AstraZeneca and Amgen.

Clinical Trials Arena 2 days ago

AZN

AMGN
POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Amgen (NASDAQ:AMGN) and AstraZeneca today announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE® (tezepelumab-ekko) significantly reduced nasal polyp severity, the need for surgery and systemic corticosteroid use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) compared to placebo.1,2 The data were published today in the New England Journal of Medicine and were highlighted as a late-breaking oral presentation during th

PR Newswire 4 days ago

AMGN
Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025

We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other AI stocks. In a recent discussion at CNBC’s ‘Squawk on the Street’, NYU professor and AI expert, Gary Marcus shared […]

Insider Monkey 5 days ago

AMGN
AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Amgen (NASDAQ: AMGN) will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner, executive vice president of Research and Development at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

PR Newswire 5 days ago

AMGN
Why Amgen Inc. (AMGN) is the Best Vaccine Stock to Buy According to Hedge Funds?

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other best vaccine store stocks to buy now. What Will Trump’s Tariffs Mean for the Pharma Industry? On February 24, […]

Insider Monkey 5 days ago

AMGN
This Could Be the Best GLP-1 Stock to Buy in 2025

The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion by 2031. Hype around weight loss drugs isn't new, but when people are losing more than 20% of their body weight, it creates considerable enthusiasm. If you're looking for a more reasonably priced investment, you may want to consider Amgen (NASDAQ: AMGN).

Motley Fool 5 days ago

AMGN
Drug Stocks Are the New Safe Bet in a Shaky Market

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

The Wall Street Journal 5 days ago

AMGN

ABBV

AZN
Is Amgen Inc. (AMGN) the Best Retirement Stock to Buy According to Hedge Funds?

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best retirement stocks to buy according to hedge funds. After much suspense, the US Federal Reserve finally began cutting interest rates […]

Insider Monkey 7 days ago

AMGN
These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?

How is the Dow Jones Industrial Average (DJINDICES: ^DJI) performing this year? If you're the half-empty kind of person, you'd probably note that the Dow hasn't gained nearly as much at this point in the year as it did in 2024. Regardless of your perspective on the overall Dow Jones index, some of its members are doing quite well.

Motley Fool 8 days ago

IBM

^DJI

AMGN
Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks gained late Monday afternoon with the NYSE Health Care Index climbing 1.1% and th

PREMIUM
MT Newswires 9 days ago

AMGN
Is Amgen Inc. (AMGN) One of the Best Performing Dow Stocks So Far in 2025?

We recently published a list of 11 Best Performing Dow Stocks So Far in 2025. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best performing Dow stocks so far in 2025. The Dow is a renowned and significant stock market index that measures the performance […]

Insider Monkey 9 days ago

AMGN

^DJI
5 Stocks in the Dow ETF That Survived the Worst Week Since October

Dow Jones witnesses its biggest weekly drop since October amid renewed concerns about economic growth. Let's look at the stocks that survived.

Zacks 9 days ago

VZ

^DJI

AMGN
The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

AbbVie, Amgen, Stryker, Dexcom and Medtronic are included in this Analyst Blog.

Zacks 9 days ago

ABBV

SYK

AMGN

Performance Overview

Return	AMG.F	S&P 500
YTD	+18.67%	-0.66%
1-Year	+18.40%	+15.04%
3-Year	+51.91%	+34.97%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Amgen Inc. (AMG.F)

Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now

Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out

Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025

With patent losses on the horizon, Amgen refocuses its business strategy

AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025

AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Why Amgen Inc. (AMGN) is the Best Vaccine Stock to Buy According to Hedge Funds?

This Could Be the Best GLP-1 Stock to Buy in 2025

Drug Stocks Are the New Safe Bet in a Shaky Market

Is Amgen Inc. (AMGN) the Best Retirement Stock to Buy According to Hedge Funds?

These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?

Sector Update: Health Care Stocks Advance Late Afternoon

Is Amgen Inc. (AMGN) One of the Best Performing Dow Stocks So Far in 2025?

5 Stocks in the Dow ETF That Survived the Worst Week Since October

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

Performance Overview